The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies
Abstract
Because of the growing focus on containing health care costs, pharmaceutical companies are trying to demonstrate the cost effectiveness of their products relative to alternatives. In Europe and Australia, economic analyses are often required for government approval and pricing of new pharmaceuticals. In the United States, such analyses are increasingly being used for marketing and to obtain formulary approval. Because of the corporate need for timely results and confidentiality about a new drug in the period before marketing begins and because other financial support is limited, pharmaceutical companies themselves sponsor most academic research into the cost effectiveness of pharmaceuticals. The . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Existence of Publication Bias and Risk Factors for Its Occurrence
Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100097014 · Cited by 1,417
Angell, M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191608 · Cited by 143
Cited by
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420020059007 · Cited by 277
Common methodological flaws in economic evaluations
Drummond, M., & Sculpher, M. (2005) · Medical Care · doi:10.1097/01.mlr.0000170001.10393.b7 · Cited by 204
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
SAFER, D. J. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200209000-00002 · Cited by 180
Barnes, D. E., & Bero, L. A. (1996) · Journal of Health Politics, Policy and Law · doi:10.1215/03616878-21-3-515 · Cited by 176
A review of the literature on ethical issues related to scientific authorship
Hosseini, M., & Gordijn, B. (2020) · Accountability in Research · doi:10.1080/08989621.2020.1750957 · Cited by 38
Metadata
- Authors
- Hillman, A. L., Eisenberg, J. M., Pauly, M. V., Bloom, B. S., Click, H., Kinosian, B., & Schwartz, J. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1991-05-09
- Volume
- 324
- Issue
- 19
- Pages
- 1362-1365
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338601379
- Cited by
- 234
- References
- 2
- FWCI
- 23.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies. https://app.cochat.ai/papers/10.1056/nejm199105093241911
- The paper
- Hillman, A. L., Eisenberg, J. M., Pauly, M. V., Bloom, B. S., Click, H., Kinosian, B., & Schwartz, J. S. (1991). Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies. New England Journal of Medicine. https://doi.org/10.1056/nejm199105093241911
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.